Abstract
Lung cancer is currently the most common malignant tumor and most lethal cancer worldwide, posing a serious threat to human life and health. Mitomycin has been widely used in the clinical treatment of malignant tumors owing to its strong antitumor effects. In this study, hyaluronic acid/carboxymethyl chitosan hydrogels loaded with mitomycin were prepared by chemical synthesis. The SEM results showed that the hydrogels had a 3D interoperable porous structure, which facilitates drug loading. Biological experiments showed that the mitomycin-loaded hydrogels remarkably reduced the viability of cancer cells and inhibited the activation of the VEGF signaling pathway in cancer cells in a dose-dependent manner. Thus, the hydrogels are expected to be used as a drug carrier material for lung cancer treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
